Elena-daniela Grigorescu

Iasi, IS 700111, Romania

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.

Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients.

Journal: Journal of clinical medicine
Published: June 05, 2025

Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review.

Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review.

Journal: Journal of clinical medicine
Published: March 11, 2025

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Journal: Journal of clinical medicine
Published: January 06, 2025

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Nutrients
Published: June 05, 2024

Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up.

Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up.

Journal: Diagnostics (Basel, Switzerland)
Published: July 28, 2023

Distinct Features of Vascular Diseases in COVID-19.

Distinct Features of Vascular Diseases in COVID-19.

Journal: Journal of inflammation research
Published: April 18, 2023

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives.

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives.

Journal: Metabolites
Published: March 22, 2023

Role of Chemerin and Perivascular Adipose Tissue Characteristics on Cardiovascular Risk Assessment by Arterial Stiffness Markers in Patients with Morbid Obesity.

Role of Chemerin and Perivascular Adipose Tissue Characteristics on Cardiovascular Risk Assessment by Arterial Stiffness Markers in Patients with Morbid Obesity.

Journal: Journal of clinical medicine
Published: February 12, 2023

Infective Endocarditis during Pregnancy-Keep It Safe and Simple!

Infective Endocarditis during Pregnancy-Keep It Safe and Simple!

Journal: Medicina (Kaunas, Lithuania)
Published: February 12, 2023

Determinants of Arterial Stiffness in Patients with Morbid Obesity. The Role of Echocardiography and Carotid Ultrasound Imaging.

Determinants of Arterial Stiffness in Patients with Morbid Obesity. The Role of Echocardiography and Carotid Ultrasound Imaging.

Journal: Medicina (Kaunas, Lithuania)
Published: January 30, 2023

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes.

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes.

Journal: Biomedicines
Published: August 27, 2022

Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients.

Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients.

Journal: Journal of personalized medicine
Published: August 05, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026